Abluminus is an abluminally caoted  Sirolimus Drug Eluting Stent which is dedicated for Diabetic and Acute Myocardial Infarction Patients. The stent and the balloon, both are coated with Sirolimus, in a pre-crimped condition which allows to treat diffused disease in coronary artery in Diabetic patients. The stent on 45 sec inflation; develops a thin bio-absorbable film which acts as a protective layer and avoids slow flow – no flow blood movement.

The DEDICATE REGISTRY is designed to establish long term benefits of unique and innovative product design of Abluminus in Diabetic indication globally.


To evaluate the performance of a novel ABLUMINUS® DES+ sirolimus eluting stent in patients with Diabetes Mellitus.


Prospective, Observational, Multi‐center clinical registry to be conducted globally at Interventional cardiology centers. 5000 patients will be enrolled and evaluated.

All the patients will be followed up for up to 5 years.


Target Lesion Failure, which is composite of cardiac death, target-vessel myocardial infarction, and clinically indicated target lesion revascularization within 12 months.


Stent thrombosis [Time Frame: 1 month, 12 months, yearly]: Definite and probable stent thrombosis according to ARC definitions;
Cardiac death [Time Frame: 1 month, 12 months, yearly];
Target Vessel Myocardial infarction [Time Frame: 1 month, 12 months, yearly];
Target Lesion Revascularisation [Time Frame: 1 month, 12 months, yearly];
Device Success at 24 hours;
Lesion Success at 24 hours;
Procedural Success at 24 hours.

Physician Survey Form
Full Name*
Date of Birth*
Hospital/Company name*
Postal Code
Primary Medical Speciality
No. of personal PCI procedures per year*
Do you face challenges in treating diabetic patients in coronary artery disease?*
Do you have any experience with novel ABLUMINUS® DES+?*
  • Head of Coronary Revascularization Unit
    Head of Clinical Research Unit
    Department of Cardiology,
    IRCCS Policlinico S. Donato, San Donato, Milan, Italy

    Watch Video

    Dedicate Healthcare - Envision Scientific - Advancing Innovation


    Dr. Luca Testa, MD, PhD

  • Interventional cardiologist
    Emodinamica Fondazione
    Poliambulanza istituto ospedaliero, Brescia, Italy

    Watch Video

    Dedicate Healthcare - Envision Scientific - Advancing Innovation


    Dr. Diego Maffeo

Translate »